HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin J Buckley Selected Research

Amiloride (Midamor)

2/2022Urokinase plasminogen activator as an anti-metastasis target: inhibitor design principles, recent amiloride derivatives, and issues with human/mouse species selectivity.
1/2022An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis.
3/2021Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors.
1/2021Systematic evaluation of structure-property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride.
12/20196-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease.
1/20186-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin J Buckley Research Topics

Disease

5Neoplasms (Cancer)
10/2022 - 01/2018
2Neoplasm Metastasis (Metastasis)
02/2022 - 01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Adenocarcinoma
01/2022
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2022
1Inflammation (Inflammations)
01/2019
1Rheumatoid Arthritis
01/2019

Drug/Important Bio-Agent (IBA)

8Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2022 - 01/2018
6Amiloride (Midamor)FDA LinkGeneric
02/2022 - 01/2018
4Plasminogen Activators (Plasminogen Activator)IBA
10/2022 - 01/2018
4DiureticsIBA
03/2021 - 01/2018
2PlasminogenIBA
01/2022 - 01/2019
2trypsin-like serine proteaseIBA
03/2021 - 12/2019
25-(N,N-hexamethylene)amilorideIBA
01/2021 - 01/2018
1Sodium-Hydrogen ExchangersIBA
03/2021
1Urokinase Plasminogen Activator ReceptorsIBA
01/2019
1PotassiumIBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
01/2018